Papers

2

Total Citations

302

H-Index

2

About

Esther Mena is a leading researcher in oncologic imaging, with a focus on improving the detection and characterization of prostate cancer. Her work bridges advanced MRI techniques and novel PET radiotracers, aiming to enhance diagnostic accuracy and guide treatment decisions. In a pivotal 2013 study, she compared endorectal coil and nonendorectal coil T2-weighted and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer, correlating findings with whole-mount histopathology. This work, cited over 155 times, helped clarify the trade-offs between patient comfort and image quality in multiparametric MRI. Concurrently, Mena investigated the novel PET radiotracer 18F-FACBC for detecting localized prostate cancer. Her 2013 study, with over 147 citations, demonstrated the tracer’s ability to differentiate malignant tissue from benign prostatic hyperplasia and normal prostate, offering a promising alternative to conventional imaging. Through these contributions, Mena has advanced noninvasive prostate cancer mapping, directly impacting clinical decision-making and patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
302
Total Citations
151
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology
155 citations · 2013
📈 Most Prolific Year: 2013 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: National Institutes of Health, National Cancer Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago